Nanologica is a Swedish nanotechnology company developing and manufacturing silica for purification by chromatography.
Nanologica’s silica for preparative chromatography, NLAB Saga®, was developed with a clear goal in mind – to increase the availability of better and cheaper medicine to a larger number of patients across the world, for the betterment of mankind.
With outstanding lifetime and efficiency, NLAB Saga® can improve productivity and reduce production costs for the manufacturers. The aim is to reduce the cost of peptide and oligonucleotide-based medicines, such as insulin and other diabetes drugs, for the benefit of patients.